The science between your molecule and the clinic.
Nuvex Biotech is a formulation R&D partner for pharma and biotech teams — developing, characterizing, and de-risking dosage forms, then packaging the data your next milestone depends on.
Senior formulation science, without the layers.
Nuvex Biotech is a contract formulation R&D lab for pharma, biotech and nutraceutical developers across North America, Europe and Asia-Pacific. It's founder-led by a formulation scientist — the person who scopes your program is the one running it at the bench.
Our focus is the science that de-risks a molecule before it scales: developing, characterizing and documenting dosage forms so your program reaches the clinic — and a GMP partner — on data that holds up.
- Founder-led
- Rx · Nutraceutical
- 5 dosage-form routes
- NA · EU · APAC
Formulation & analytical R&D
Six disciplines, one continuous data trail.
From the first excipient screen to a tech-transfer-ready package, every result is generated in-house and documented to carry forward — no gaps between the science and the paperwork.
Formulation Development
Pre-formulation to prototype — excipient screening, compatibility, solubility and dosage-form design around your target profile.
- PRE-FORMULATION
- EXCIPIENT SCREEN
- PROTOTYPING
R&D and Innovation
Mechanistic problem-solving for hard-to-formulate molecules, novel delivery routes, and IP-generating development.
- DELIVERY
- TROUBLESHOOTING
- NOVEL IP
Analytical Method Development
Method development and validation — assay, impurity, chiral and release testing that makes data defensible.
- METHOD DEV
- VALIDATION
- CHIRAL / HPLC
Stability Programs
ICH-aligned stability design, forced degradation and shelf-life modeling built to hold up under review.
- ICH DESIGN
- FORCED DEG
- SHELF-LIFE
Product Development & Scale-up Support
Bench-to-manufacture: process understanding, batch scale-up and tech-transfer-ready parameters.
- PROCESS
- SCALE-UP
- TECH TRANSFER
Regulatory & CMC Consulting
CMC narratives, gap analysis and documentation to carry your formulation into GMP manufacture.
- CMC NARRATIVE
- GAP ANALYSIS
- DOSSIER
From concept to clinical readiness.
A staged path that takes a compound from feasibility to a package your manufacturing partner can pick up without rework.
Feasibility & pre-formulation
Physicochemical profiling, route assessment and a go / no-go read on your target profile.
Formulation R&D
Iterative prototyping and optimization against release, stability and processability.
Analytical development
Methods developed and validated to support every downstream claim and specification.
Stability & data package
Evidence assembled into a coherent, review-ready dossier — not scattered results.
Tech transfer & clinical readiness
Documentation handed off so a qualified GMP partner can scale without re-deriving the science.
Formulation assets, ready to license.
Alongside client-funded programs, Nuvex develops its own de-risked formulation IP — independent assets available for license or co-development, so your pipeline can start a step ahead of the bench.
Explore the asset portfolioSenior science on every program — no hand-offs.
Lean by design. The scientist scoping your project is the one running it, so decisions stay fast, accountable and technically precise.
Direct, senior-led work
No junior relay. Your program is led hands-on by a formulation scientist, keeping intent intact from scope to data.
Documentation that travels
Results are captured to move — into a submission, a partner, or a GMP site — without a second round of interpretation.
Built for outside review
Methods, stability and CMC framing are structured for the people who scrutinize them, not just for internal use.
Have a molecule that needs a formulation?
Send the target profile and where it stands today. You'll get a straight read on feasibility, scope and the path to clinic-ready data.